452 related articles for article (PubMed ID: 32727215)
1. Histone deacetylases in modulating cardiac disease and their clinical translational and therapeutic implications.
Wang Z; Zhao YT; Zhao TC
Exp Biol Med (Maywood); 2021 Jan; 246(2):213-225. PubMed ID: 32727215
[TBL] [Abstract][Full Text] [Related]
2. The important role of histone deacetylases in modulating vascular physiology and arteriosclerosis.
Zhao TC; Wang Z; Zhao TY
Atherosclerosis; 2020 Jun; 303():36-42. PubMed ID: 32535412
[TBL] [Abstract][Full Text] [Related]
3. The nonepigenetic role for small molecule histone deacetylase inhibitors in the regulation of cardiac function.
Romanick SS; Ferguson BS
Future Med Chem; 2019 Jun; 11(11):1345-1356. PubMed ID: 31161804
[TBL] [Abstract][Full Text] [Related]
4. Roles and targets of class I and IIa histone deacetylases in cardiac hypertrophy.
Kee HJ; Kook H
J Biomed Biotechnol; 2011; 2011():928326. PubMed ID: 21151616
[TBL] [Abstract][Full Text] [Related]
5. Targeting histone deacetylases for heart diseases.
Jin G; Wang K; Zhao Y; Yuan S; He Z; Zhang J
Bioorg Chem; 2023 Sep; 138():106601. PubMed ID: 37224740
[TBL] [Abstract][Full Text] [Related]
6. Posttranslational modifications of histone deacetylases: implications for cardiovascular diseases.
Eom GH; Kook H
Pharmacol Ther; 2014 Aug; 143(2):168-80. PubMed ID: 24594235
[TBL] [Abstract][Full Text] [Related]
7. Histone Deacetylases in Kidney Physiology and Acute Kidney Injury.
Hyndman KA
Semin Nephrol; 2020 Mar; 40(2):138-147. PubMed ID: 32303277
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylases: a saga of perturbed acetylation homeostasis in cancer.
Parbin S; Kar S; Shilpi A; Sengupta D; Deb M; Rath SK; Patra SK
J Histochem Cytochem; 2014 Jan; 62(1):11-33. PubMed ID: 24051359
[TBL] [Abstract][Full Text] [Related]
9. HDAC inhibition attenuates cardiac hypertrophy by acetylation and deacetylation of target genes.
Ooi JY; Tuano NK; Rafehi H; Gao XM; Ziemann M; Du XJ; El-Osta A
Epigenetics; 2015; 10(5):418-30. PubMed ID: 25941940
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase (HDACs) inhibitors: Clinical applications.
Shanmukha KD; Paluvai H; Lomada SK; Gokara M; Kalangi SK
Prog Mol Biol Transl Sci; 2023; 198():119-152. PubMed ID: 37225317
[TBL] [Abstract][Full Text] [Related]
11. HDACs and HDAC Inhibitors in Cancer Development and Therapy.
Li Y; Seto E
Cold Spring Harb Perspect Med; 2016 Oct; 6(10):. PubMed ID: 27599530
[TBL] [Abstract][Full Text] [Related]
12. Histone Deacetylase Inhibitors Modulating Non-epigenetic Players: The Novel Mechanism for Small Molecule Based Therapeutic Intervention.
Ganai SA
Curr Drug Targets; 2018; 19(6):593-601. PubMed ID: 27231104
[TBL] [Abstract][Full Text] [Related]
13. Role of Histone Deacetylases (HDACs) in Epilepsy and Epileptogenesis.
Citraro R; Leo A; Santoro M; D'agostino G; Constanti A; Russo E
Curr Pharm Des; 2017; 23(37):5546-5562. PubMed ID: 29076408
[TBL] [Abstract][Full Text] [Related]
14. Innovative Strategies for Selective Inhibition of Histone Deacetylases.
Maolanon AR; Madsen AS; Olsen CA
Cell Chem Biol; 2016 Jul; 23(7):759-768. PubMed ID: 27447046
[TBL] [Abstract][Full Text] [Related]
15. The emerging roles of HDACs and their therapeutic implications in cancer.
Hai R; Yang D; Zheng F; Wang W; Han X; Bode AM; Luo X
Eur J Pharmacol; 2022 Sep; 931():175216. PubMed ID: 35988787
[TBL] [Abstract][Full Text] [Related]
16. The role of dietary histone deacetylases (HDACs) inhibitors in health and disease.
Bassett SA; Barnett MP
Nutrients; 2014 Oct; 6(10):4273-301. PubMed ID: 25322459
[TBL] [Abstract][Full Text] [Related]
17. Chromatin modifications remodel cardiac gene expression.
Mathiyalagan P; Keating ST; Du XJ; El-Osta A
Cardiovasc Res; 2014 Jul; 103(1):7-16. PubMed ID: 24812277
[TBL] [Abstract][Full Text] [Related]
18. Protein acetylation in the cardiorenal axis: the promise of histone deacetylase inhibitors.
Bush EW; McKinsey TA
Circ Res; 2010 Feb; 106(2):272-84. PubMed ID: 20133912
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylases as therapeutic targets--from cancer to cardiac disease.
Abend A; Kehat I
Pharmacol Ther; 2015 Mar; 147():55-62. PubMed ID: 25444758
[TBL] [Abstract][Full Text] [Related]
20. The potential of targeting epigenetic regulators for the treatment of fibrotic cardiac diseases.
Schuetze KB; Koch KA; McKinsey TA
Future Med Chem; 2016 Sep; 8(13):1533-6. PubMed ID: 27556930
[No Abstract] [Full Text] [Related]
[Next] [New Search]